UNIGE document Scientific Article
previous document  unige:16944  next document
add to browser collection
Title

Follow-up of the metabolic syndrome induced by atypical antipsychotics: recommendations and pharmacogenetics perspectives

Authors
Solida, A
Lechaire, C
Conus, P
Published in Revue médicale suisse. 2008, vol. 4, no. 171, p. 1994-6,1998-9
Abstract Despite a better overall tolerance as compared to classical antipsychotics, atypical antipsychotics are not devoid of side-effects, notably metabolic factors (weight gain, alteration of lipid and glucose profile). These side-effects are very troubling concerning long term morbidity and mortality and may also influence compliance towards drugs. The department of psychiatry of the Hospital University Centre has established a guideline on the clinical monitoring of patients receiving atypical antipsychotics, based on recently published consensus, which will be presented here. In addition, recent studies show that weight gain and metabolic alterations induced by this type of medication may be influenced by the genetic background of the patients. Such studies should allow, in the near future, to adapt the treatment for each patient.
Keywords Antidepressive Agents, Second-Generation/adverse effectsGlucose Intolerance/chemically inducedHumansLeptin/geneticsMetabolic Syndrome X/chemically induced/geneticsPharmacogeneticsReceptors, Leptin/geneticsWeight Gain/drug effects
Identifiers
PMID: 18847133
Full text
Article (Author postprint) (201 Kb) - public document Free access
Structures
Citation
(ISO format)
CHOONG, Eva et al. Follow-up of the metabolic syndrome induced by atypical antipsychotics: recommendations and pharmacogenetics perspectives. In: Revue médicale suisse, 2008, vol. 4, n° 171, p. 1994-6,1998-9. https://archive-ouverte.unige.ch/unige:16944

220 hits

178 downloads

Update

Deposited on : 2011-09-16

Export document
Format :
Citation style :